"Empowering clinicians with advanced surgical technology and intelligent collaboration tools."
We’re advancing endoscopic technology to enhance visualisation, precision, and diagnostic accuracy at the point of care.
Through real-time telestration and knowledge-sharing tools, we support better clinical decision-making and surgical training.
Our solutions are designed to empower clinicians and improve surgical outcomes — wherever care is delivered.
Founder & Chief Executive Officer
Fareed is a former colorectal surgeon and founder of SurgEase.
After treating people with serious colorectal diseases for over 10 years, he has used these experiences as the main motivation to develop SurgEase's technologies.
His focus in quality of care, improving patient outcomes and building technologies to solve real world problems remains his passion and vision.
International Business Development Lead
Managing Director Software
Head of Finance
Head of Software Development
.svg)
SurgEase Innovations, in collaboration with University Hospitals of North Midlands NHS Trust and Medinet, was shortlisted in the Best Elective Care Recovery Initiative category for their dual-procedure mobile endoscopy unit, delivering over 725 appointments monthly to address overdue surveillance cases.
SurgEase Innovations obtained FDA 510(k) clearance for the LumenEye X1, enabling its entry into the U.S. market.
SurgEase received funding from Innovate UK for the project titled "Remote community-based digital rectoscopy for patients with rectal disease during Covid-19 Pandemic," highlighting the company's role in addressing healthcare challenges during the pandemic.
